232 related articles for article (PubMed ID: 27431859)
1. EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.
Thimsen V; Hölsken A; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Losa M; Jones DT; Buslei R
Sci Rep; 2016 Jul; 6():29731. PubMed ID: 27431859
[TBL] [Abstract][Full Text] [Related]
2. TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology.
Liu Y; Wang CH; Li DL; Zhang SC; Peng YP; Peng JX; Song Y; Qi ST; Pan J
Oncotarget; 2016 Aug; 7(31):50564-50574. PubMed ID: 27409178
[TBL] [Abstract][Full Text] [Related]
3. BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts.
Schweizer L; Capper D; Hölsken A; Fahlbusch R; Flitsch J; Buchfelder M; Herold-Mende C; von Deimling A; Buslei R
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):733-42. PubMed ID: 25442675
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes.
Coy S; Du Z; Sheu SH; Woo T; Rodriguez FJ; Kieran MW; Santagata S
Mod Pathol; 2016 Dec; 29(12):1446-1459. PubMed ID: 27562488
[TBL] [Abstract][Full Text] [Related]
5. Rathke's cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging.
Kunii N; Abe T; Kawamo M; Tanioka D; Izumiyama H; Moritani T
Acta Neurochir (Wien); 2007 Aug; 149(8):759-69; discussion 769. PubMed ID: 17594050
[TBL] [Abstract][Full Text] [Related]
6. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical assessment of craniopharyngioma and related lesions.
Le BH; Towfighi J; Kapadia SB; Lopes MB
Endocr Pathol; 2007; 18(1):23-30. PubMed ID: 17652797
[TBL] [Abstract][Full Text] [Related]
8. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cyst.
Xin W; Rubin MA; McKeever PE
Arch Pathol Lab Med; 2002 Oct; 126(10):1174-8. PubMed ID: 12296753
[TBL] [Abstract][Full Text] [Related]
10. BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma.
Kim JH; Paulus W; Heim S
J Neurooncol; 2015 May; 123(1):189-91. PubMed ID: 25820214
[No Abstract] [Full Text] [Related]
11. Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.
Esheba GE; Hassan AA
J Egypt Natl Canc Inst; 2015 Sep; 27(3):139-45. PubMed ID: 26198262
[TBL] [Abstract][Full Text] [Related]
12. Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.
Thimsen V; John N; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Knosp E; Losa M; Buslei R; Hölsken A
Sci Rep; 2017 Nov; 7(1):15856. PubMed ID: 29158570
[TBL] [Abstract][Full Text] [Related]
13. Pituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke's cleft cysts, craniopharyngiomas, and meningiomas.
Dusick JR; Fatemi N; Mattozo C; McArthur D; Cohan P; Wang C; Swerdloff RS; Kelly DF
Surg Neurol; 2008 Nov; 70(5):482-90; discussion 490-1. PubMed ID: 18482750
[TBL] [Abstract][Full Text] [Related]
14. Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
Stache C; Hölsken A; Fahlbusch R; Flitsch J; Schlaffer SM; Buchfelder M; Buslei R
Neuro Oncol; 2014 Jan; 16(2):256-64. PubMed ID: 24305709
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
Coy S; Rashid R; Lin JR; Du Z; Donson AM; Hankinson TC; Foreman NK; Manley PE; Kieran MW; Reardon DA; Sorger PK; Santagata S
Neuro Oncol; 2018 Jul; 20(8):1101-1112. PubMed ID: 29509940
[TBL] [Abstract][Full Text] [Related]
16. Rathke's cleft cysts with significant squamous metaplasia--high risk of postoperative deterioration and close origins to craniopharyngioma.
Ogawa Y; Watanabe M; Tominaga T
Acta Neurochir (Wien); 2013 Jun; 155(6):1069-75. PubMed ID: 23371400
[TBL] [Abstract][Full Text] [Related]
17. Late development of craniopharyngioma following surgery for Rathke's cleft cyst.
Park YS; Ahn JY; Kim DS; Kim TS; Kim SH
Clin Neuropathol; 2009; 28(3):177-81. PubMed ID: 19537134
[TBL] [Abstract][Full Text] [Related]
18. Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach.
Hofmann BM; Kreutzer J; Saeger W; Buchfelder M; Blümcke I; Fahlbusch R; Buslei R
Am J Surg Pathol; 2006 Dec; 30(12):1595-603. PubMed ID: 17122517
[TBL] [Abstract][Full Text] [Related]
19. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas.
Tateyama H; Tada T; Okabe M; Takahashi E; Eimoto T
Pathol Res Pract; 2001; 197(11):735-42. PubMed ID: 11770017
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.
Martinez-Gutierrez JC; D'Andrea MR; Cahill DP; Santagata S; Barker FG; Brastianos PK
Neurosurg Focus; 2016 Dec; 41(6):E2. PubMed ID: 27903124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
